Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome I: Introduction
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Irritable Bowel Syndrome
Irritable Bowel Syndrome III: Medical and Nursing Management
Assessment of the Gastrointestinal System I: Subjective Data
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 5, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Elaine F Harkness1, Laura Grant, Sarah J O'Brien
1Institute of Inflammation and Repair, Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PL, UK. Elaine.F.Harkness@manchester.ac.uk.
Estimating irritable bowel syndrome (IBS) prevalence using primary care records is challenging. The study found that the IBS diagnostic code is rarely used, leading to underestimation of community prevalence.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: